<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase II:   Software for Micro RNA Detection and Analysis</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>08/15/2005</AwardEffectiveDate>
<AwardExpirationDate>07/31/2008</AwardExpirationDate>
<AwardTotalIntnAmount>0.00</AwardTotalIntnAmount>
<AwardAmount>506759</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Gregory T. Baxter</SignBlockName>
<PO_EMAI/>
<PO_PHON/>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research (SBIR) Phase II project will develop machine learning tools for RNA gene detection. Prior Phase I research resulted in the successful development of artificial neural networks for the discrimination of functional RNA (fRNA) coding regions from non-coding regions in four model eukaryotes. The Phase II project will focus on (1) refinement of best evolved neural networks for 10 key eukaryotes capable of discriminating fRNA coding from non-coding sequence information, (2) experimental verification of predicted fRNA coding regions in human and mouse, (3) development of machine learning algorithms capable of discriminating between eukaryotic fRNA subtypes, (4) extension of the approach to include machine learning tools capable of discriminating between fRNA subtypes and to evaluate this potential for additional functionality, and (5) development of a user-friendly graphical user interface (GUI) for the product.&lt;br/&gt;&lt;br/&gt;The commercial application of this project will be to identify a new class of targets for drug design and  discovery for the pharmaceutical industry. The educational aspects of the proposed work will be to assist in dissemination of knowledge about the importance of fRNAs to the next generation of scientists.</AbstractNarration>
<MinAmdLetterDate>08/08/2005</MinAmdLetterDate>
<MaxAmdLetterDate>10/15/2007</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0522270</AwardID>
<Investigator>
<FirstName>Gary</FirstName>
<LastName>Fogel</LastName>
<PI_MID_INIT>B</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Gary B Fogel</PI_FULL_NAME>
<EmailAddress>gfogel@natural-selection.com</EmailAddress>
<PI_PHON>8584556449</PI_PHON>
<NSF_ID>000438689</NSF_ID>
<StartDate>08/08/2005</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>NATURAL SELECTION, INCORPORATED</Name>
<CityName>San Diego</CityName>
<CountyName>SAN DIEGO</CountyName>
<ZipCode>921213921</ZipCode>
<PhoneNumber>8584556449</PhoneNumber>
<StreetAddress>6480 WEATHERS PLACE, SUITE 350</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>52</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA52</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>926035262</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>NATURAL SELECTION, INCORPORATED</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[NATURAL SELECTION, INCORPORATED]]></Name>
<CityName>San Diego</CityName>
<CountyName>SAN DIEGO</CountyName>
<StateCode>CA</StateCode>
<ZipCode>921213921</ZipCode>
<StreetAddress><![CDATA[6480 WEATHERS PLACE, SUITE 350]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>52</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA52</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>5373</Code>
<Text>SBIR Phase II</Text>
</ProgramElement>
<ProgramReference>
<Code>9181</Code>
<Text>BIOPROCESSING/BIOMOLECULAR MATERIALS</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
<Appropriation>
<Code>0105</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0106</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>490100</APP_SYMB_ID>
</Appropriation>
<Appropriation>
<Code>0108</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2005~405905</FUND_OBLG>
<FUND_OBLG>2006~30855</FUND_OBLG>
<FUND_OBLG>2008~69999</FUND_OBLG>
</Award>
</rootTag>
